Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frequency: Safety of Transitioning to Peginterferon Beta-1a in RMS
NCT02234869Phase 4Withdrawn
- Sponsor
- Biogen
- Start
- Oct 2014
- Primary completion
- Feb 2017
- Modality
- Interferons
01
Overview
A Phase 4 trial of interferon beta in multiple sclerosis (MS), sponsored by Biogen. Planned start Oct 2014; status: withdrawn.
02
Drugs
interferon beta
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02234869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02234869.